Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 18/20 | 0.76 |
| ▸ | ESR2 | Q92731 | 17/20 | 0.76 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.64 |
| ▸ | LTA4H | P09960 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6597509 | 0.94 | ITGA4 (0.72) | ESR1ESR2ITGA4LTA4H | |
| Hydrochloric Acid SCHEMBL6551286 | 0.91 | ESR1 (0.76) | ESR1ESR2ITGA4LTA4H | |
| SCHEMBL7938571 | 0.90 | ESR1 (0.81) | ESR1ESR2ITGA4 | |
| Hydrochloric Acid SCHEMBL6550274 | 0.89 | ESR1 (0.74) | ESR1ESR2ITGA4LTA4H | |
| SCHEMBL7924348 | 0.89 | ESR1 (0.80) | ESR1ESR2ITGA4 | |
| Hydrochloric Acid SCHEMBL6551013 | 0.86 | ESR1 (0.70) | ESR1ESR2ITGA4LTA4H | |
| SCHEMBL17154287 | 0.86 | ESR1 (1.00) | ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL7106607 | 0.86 | ESR1 (0.66) | ESR1ESR2ITGA4 | |
| SCHEMBL24654407 | 0.85 | ESR1 (0.98) | ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL7105379 | 0.84 | ESR1 (0.61) | ESR1ESR2ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0729956-B1 | Benzothiophene compounds, intermediates, compositions, and methods | LILLY CO ELI (US) | 2001-10-31 | — | — | EP | disclosed |
| EP-1113013-A1 | Benzothiophene compounds, intermediates, compositions and methods | Eli Lilly & Company (US) | 2001-07-04 | — | — | EP | disclosed |
| US-6197790-B1 | OSTEOPOROSIS | ELI LILLY AND COMPANY | 2001-03-06 | — | — | US | disclosed |
| US-6030986-A | POST-MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION; ESTROGEN INDUCED UTERINE CANCER; OSTEOPOROSIS; RESTENOSIS; CARDIOVASCULAR DISORDERS | ELI LILLY AND COMPANY (US) | 2000-02-29 | — | — | US | disclosed |
| US-5998441-A | ANTICHOLESTEROL AGENT; MIXTURE WITH ESTROGEN | ELI LILLY AND COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| US-5986109-A | UROGENITAL DISORDERS, CARDIOVASCULAR DISORDERS AND ANTICARCINOGENIC AGENTS | ELI LILLY AND COMPANY (US) | 1999-11-16 | — | — | US | disclosed |
| US-5981765-A | FOR TREATMENT OF POST-MENOPAUSAL SYNDROME INCLUDING OSTEOPOROSIS, CARDIOVASCULAR EFFECTS SUCH AS HYPERLIPIDEMIA, AND ESTROGEN-DEPENDENT CANCER, PARTICULARLY BREAST AND UTERINE CANCER | ELI LILLY AND COMPANY (US) | 1999-11-09 | — | — | US | disclosed |
| US-5977093-A | INHIBITING ESTROGEN-DEPENDENT CANCER | ELI LILLY AND COMPANY (US) | 1999-11-02 | — | — | US | disclosed |
| US-5969142-A | OXIDIZING SULFUR ATOM OF SUBSTITUTED BENZOTHIOPHENE, REACTING PRODUCT WITH NUCLEOPHILIC GROUP, REDUCING PRODUCT TO DESIRED COMPOUND | ELI LILLY AND COMPANY (US) | 1999-10-19 | — | — | US | disclosed |
| EP-0729956-A1 | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| US-5492922-A | PREVENTING RESTENOSIS | ELI LILLY AND COMPANY (US) | 1996-02-20 | — | — | US | disclosed |
| US-5488058-A | UROGENITAL DISORDERS OR OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1996-01-30 | — | — | US | disclosed |